KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Depreciation and Depletion (2016 - 2025)

Historic Depreciation and Depletion for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $192.0 million.

  • AbbVie's Depreciation and Depletion rose 52.36% to $192.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $765.0 million, marking a year-over-year increase of 268.46%. This contributed to the annual value of $764.0 million for FY2024, which is 159.57% up from last year.
  • As of Q3 2025, AbbVie's Depreciation and Depletion stood at $192.0 million, which was up 52.36% from $186.0 million recorded in Q2 2025.
  • AbbVie's 5-year Depreciation and Depletion high stood at $223.0 million for Q3 2021, and its period low was $173.0 million during Q4 2021.
  • Moreover, its 5-year median value for Depreciation and Depletion was $191.0 million (2024), whereas its average is $192.4 million.
  • The largest annual percentage gain for AbbVie's Depreciation and Depletion in the last 5 years was 7913.04% (2021), contrasted with its biggest fall of 2378.85% (2021).
  • Over the past 5 years, AbbVie's Depreciation and Depletion (Quarter) stood at $173.0 million in 2021, then rose by 13.29% to $196.0 million in 2022, then decreased by 4.59% to $187.0 million in 2023, then rose by 10.16% to $206.0 million in 2024, then dropped by 6.8% to $192.0 million in 2025.
  • Its Depreciation and Depletion stands at $192.0 million for Q3 2025, versus $186.0 million for Q2 2025 and $181.0 million for Q1 2025.